Treatment of Balanitis

Initial Assessment and Etiology

The American Urological Association recommends that for most cases of balanitis, topical antifungal agents, such as clotrimazole or miconazole cream applied twice daily for 7 days, should be first-line therapy, as Candida species are the most common infectious cause 1, 2
Fungal balanitis, the most common type, presents with erythematous areas on the glans with pruritus, white discharge, or satellite lesions, and risk factors include diabetes, immunosuppression, SGLT2 inhibitor use, poor hygiene, and uncircumcised status 1, 2
Lichen sclerosus, a chronic condition, presents with white, atrophic patches with potential for malignant transformation, and biopsy is mandatory to rule out squamous cell carcinoma, with a 2-9% malignant transformation risk 3, 4, 5

For candidal balanitis, the Centers for Disease Control and Prevention recommends topical antifungals, such as clotrimazole 1% cream or miconazole 2% cream applied twice daily for 7 days, which achieves symptom resolution in 91% of patients and mycological cure in 90% 1, 2
For extensive or recurrent candidal infections, the American Urological Association recommends oral fluconazole 150 mg as a single dose, with longer duration for recurrent cases 1, 2
For bacterial balanitis, the Centers for Disease Control and Prevention recommends treating erosive or purulent presentations with azithromycin 1 g orally as a single dose or doxycycline 100 mg orally twice daily for 7 days 6, 7, 1

The American Diabetes Association recommends screening for diabetes in all patients with balanitis, particularly those with recurrent infections 2
The Centers for Disease Control and Prevention recommends sexual abstinence for 7 days after single-dose therapy or until completion of treatment regimen if bacterial etiology is suspected 6, 7
Proper genital hygiene, including gentle cleansing with warm water and avoiding strong soaps and irritants, is essential for preventing balanitis 1, 2

The American Urological Association recommends returning for evaluation if symptoms persist after completing therapy or recur within 2 months 1, 2
For recurrent candidal infections, the American Urological Association recommends considering prophylactic antifungal therapy and investigating underlying immunosuppression or uncontrolled diabetes 1, 2

The Centers for Disease Control and Prevention recommends monitoring for signs of Fournier's gangrene or spreading infection, including fever, severe pain, extensive erythema or swelling beyond the glans, and systemic symptoms, which mandate immediate surgical consultation and broad-spectrum antibiotics 1, 6

The American Urological Association recommends not using combination antifungal-corticosteroid preparations without definitive diagnosis, as steroids worsen fungal infections 2
The American Urological Association recommends not assuming all cases are candidal without appropriate testing, as bacterial causes require different treatment 2
The American Urological Association recommends not delaying biopsy in chronic, atrophic, or treatment-resistant cases due to malignancy risk 3, 4, 5